Finland’s Mobidiag secures €25 million from EIB

Finland’s Mobidiag secures €25 million from EIB


Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+

The European Investment Bank is providing a €25 million loan to Mobidiag, a Finnish molecular diagnostics company addressing the spread of infectious diseases and antimicrobial resistance.

 

This new four-year loan will allow Mobidiag to advance its research and development and to further commercialize its molecular diagnostics tests in order to provide innovative and differentiated solutions that are adopted by key laboratories throughout Europe.
The loan is supported by the European Fund for Strategic Investments, the main pillar of the Investment Plan for Europe, through the European Growth Finance Facility initiative. Mobidiag will use it to continue to seek growth through the extension of its series of products.

Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+